What determines ageing of the transplanted liver?

HPB

Volumn 17, Issue 3, 2015, Pages 222-225

  Hodgson, Russell ^a   Christophi, Chris ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; KI 67 ANTIGEN; REGUCALCIN;

AGING; CELLULAR SENESCENCE; DATA BASE; HUMAN; LIVER CELL; LIVER GRAFT; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MEDLINE; REJUVENATION; REVIEW; SENESCENCE; STRESS; TELOMERE; ADULT; BLOOD; CAUSE OF DEATH; CHILD; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; LIVER FAILURE; LIVING DONOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SURVIVAL;

ADULT; AGING; BIOMARKERS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TELOMERE;

EID: 84922674162     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12339     Document Type: Review

References (46)

1. Fouquet V, Alves A, Branchereau S, Grabar S, Debray D, Jacquemin E, et al. (2005) Long-term outcome of pediatric liver transplantation for biliary atresia: a 10-year follow-up in a single center. Liver Transpl 11: 152-160.
2. Kelly DA,. (2006) Current issues in pediatric transplantation. Pediatr Transplant 10: 712-720.
3. Moyzis R, Buckingham J, Cram L, Dani M, Deaven L, Jones M, et al. (1988) A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 85: 6622-6626.
4. Hayflick L, Moorhead P,. (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621.
5. Melk A, Halloran P,. (2001) Cell senescence and its implications for nephrology. J Am Soc Nephrol 12: 385-393.
6. Aini W, Miyagawa-Hayashino A, Tsuruyama T, Hashimoto S, Sumiyoshi S, Ozeki M, et al. (2012) Telomere shortening and karyotypic alterations in hepatocytes in long-term transplanted human liver allografts. Transpl Int 25: 956-966.
7. Halloran P, Melk A, Barth C,. (1999) Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 10: 167-181.
8. Melk A, Schmidt BMW, Vongwiwatana A, Rayner DC, Halloran PF,. (2005) Increased expression of senescence-associated cell cycle inhibitor p16INK4a in deteriorating renal transplants and diseased native kidney. Am J Transplant 5: 1375-1382.
9. Evans HM, Kelly DA, McKiernan PJ, Hübscher S,. (2006) Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 43: 1109-1117.
10. Ekong UD, Melin-Aldana H, Seshadri R, Lokar J, Harris D, Whitington PF, et al. (2008) Graft histology characteristics in long-term survivors of pediatric liver transplantation. Liver Transpl 14: 1582-1587.
11. Scheenstra R, Peeters P, Verkade H, Gouw A,. (2009) Graft fibrosis after pediatric liver transplantation: ten years of follow-up. Hepatology 49: 880-886.
12. McGlynn LM, Stevenson K, Lamb K, Zino S, Brown M, Prina A, et al. (2009) Cellular senescence in pretransplant renal biopsies predicts postoperative organ function. Aging Cell 8: 45-51.
13. Álamo J, Barrera L, Marín L, Bernal C, Suárez G, Serrano J, et al. (2011) Results of liver transplantation with donors older than 70 years: a case-control study. Transplant Proc 43: 2227-2229.
14. Serrano M, Garcia-Gil A, Arenas J, Ber Y, Cortes L, Valiente C, et al. (2010) Outcome of liver transplantation using donors older than 60 years. Clin Transplant 24: 543-549.
15. Wang C, Jurk D, Maddick M, Nelson G, Martin-Ruiz C, Von Zglinicki T,. (2009) DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8: 311-323.
16. Houtkooper R, Argmann C, Houten S, Canto C, Jeninga E, Andreux P, et al. (2011) The metabolic footprint of aging in mice. Sci Rep 1: 134.
17. Lee J, Ward W, Ren H, Vallanat B, Darlington G, Han E, et al. (2012) Meta-analysis of gene expression in the mouse liver reveals biomarkers associated with inflammation increased early during aging. Mech Ageing Dev 133: 467-478.
18. Westhoff J, Schildhorn C, Jacobi C, Hömme M, Hartner A, Braun H, et al. (2010) Telomere shortening reduces regenerative capacity after acute kidney injury. J Am Soc Nephrol 21: 327-336.
19. Satyanarayana A, Wiemann S, Buer J, Lauber J, Dittmar K, Wustefeld T, et al. (2003) Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J 22: 4003-4013.
20. Joosten S, van Ham V, Nolan C, Borrias M, Jardine A, Shiels P, et al. (2003) Telomere shortening and cellular senescence in a model of chronic renal allograft rejection. Am J Pathol 162: 1305-1312.
21. Melk A, Ramassar V, Helms LM, Moore R, Rayner D, Solez K, et al. (2000) Telomere shortening in kidneys with age. J Am Soc Nephrol 11: 444-453.
22. Cherif H, Tarry J, Ozanne S, Hales C,. (2003) Ageing and telomeres: a study into organ- and gender-specific telomere shortening. Nucleic Acids Res 31: 1576-1583.
23. Schmelzer E, Reid L,. (2009) Human telomerase activity, telomerase and telomeric template expression in hepatic stem cells and in livers from fetal and postnatal donors. Eur J Gastroenterol Hepatol 21: 1191-1198.
24. Aikata H, Takaishi H, Kawakami Y, Takahashi S, Kitamoto M, Nakanishi T, et al. (2000) Telomere reduction in human liver tissues with age and chronic inflammation. Exp Cell Res 256: 578-582.
25. Takubo K, Nakamura K, Izumiyama N, Furugori E, Sawabe M, Arai T, et al. (2000) Telomere shortening with aging in human liver. J Gerontol 55A: B533-B536.
26. Verma S, Tachtatzis P, Penrhyn-Lowe S, Scarpini C, Jurk D, Von Zglinicki T, et al. (2012) Sustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver. Hepatology 56: 1510-1520.
27. de Grey A,. (2000) Response to 'telomere shortening with aging in human liver'. J Gerontol A Biol Sci Med Sci 56: B237-B238.
28. Daniali L, Benetos A, Susser E, Kark J, Labat C, Kimura M, et al. (2013) Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun 4: 1597.
29. Fujita T, Uchida K, Maruyama N,. (1992) Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1116: 112-128.
30. Fujisawa K, Terai S, Hirose Y, Takami T, Yamamoto N, Sakaida I,. (2011) Senescence marker protein 30 (SMP30)/regulacin (RGN) expression decreases with aging, acute liver injuries and tumors in zebrafish. Biochem Biophys Res Commun 414: 331-336.
31. Fujita T,. (1999) Senescence marker protein-30 (SMP30): structure and biological function. Biochem Biophys Res Commun 254: 1-4.
32. Fujita T, Shirasawa T, Maruyama N,. (1996) Isolation and characterization of genomic and cDNA clones encoding mouse senescence marker protein-30 (SMP30). Biochim Biophys Acta 1308: 49-57.
33. Fujita T, Shirasawa T, Uchida K, Maruyama N,. (1996) Gene regulation of senescence marker protein-30 (SMP30): coordinated up-regulation with tissue maturation and gradual down-regulation with aging. Mech Ageing Dev 87: 219-229.
34. Park J-K, Ki M-R, Hong I-H, Ji A-R, Ishigami A, Park S-I, et al. (2009) Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice. Hepatology 51: 1766-1777.
35. Ishigami A, Fujita T, Handa S, Shirasawa T, Koseki H, Kitamura T, et al. (2002) Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas-mediated apoptosis. Am J Pathol 161: 1273-1281.
36. Maruyama N, Ishigami A, Kondo Y,. (2010) Pathophysiological significance of senescence marker protein-30. Geriatr Gerontol Int 10: S88-S98.
37. Eguchi S, Takatsuki M, Hidaka M, Soyama A, Muraoka I, Tomonaga T, et al. (2010) Lack of grafted liver rejuvenation in adult-to-pediatric liver transplantation. Dig Dis Sci 56: 1542-1547.
38. Melk A, Schmidt B, Takeuchi O, Sawitzki B, Rayner D, Halloran P,. (2004) Expression of p16INK4a and other cell regulator and senescence associated genes in aging human kidney. Kidney Int 65: 510-520.
39. Koppelstaetter C, Schratzberger G, Perco P, Hofer J, Mark W, Ollinger R, et al. (2008) Markers of cellular senescence in zero hour biopsies predict outcome in renal transplantation. Aging Cell 7: 491-497.
40. Erickson R, Dunning L, Holtzman J,. (2006) The effect of aging on the chaperone concentrations in the hepatic, endoplasmic reticulum of male rats: the possible role of protein misfolding due to the loss of chaperones in the decline in physiological function seen with age. J Gerontol A Biol Sci Med Sci 61: 435-443.
41. Marino M, Dolfi C, Paradiso C, Cavallini G, Masini M, Gori Z, et al. (1998) Age-dependent accumulation of dolichol in rat liver: is tissue dolichol a biomarker of aging? J Gerontol A Biol Sci Med Sci 53: B87-B93.
42. Izzotti A, Cartiglia C, Taningher M, De Flora S, Balansky R,. (1999) Age-related increases of 8-hydroxy-2'-deoxyguanosine and DNA-protein crosslinks in mouse organs. Mutat Res 446: 215-223.
43. Mura C, Gong X, Taylor A, Villalobos-Molina R, Scrofano M,. (1996) Effects of calorie restriction and aging on the expression of antioxidant enzymes and ubiquitin in the liver of Emory mice. Mech Ageing Dev 91: 115-129.
44. Czekaj P, Bryzek A, Czekaj T, Koryciak-Komarska H, Wiaderkiewicz A, Plewka D, et al. (2010) Cytochrome P450 mRNA expressions along with in vitro differentiation of hepatocyte precursor cells from fetal, young and old rats. Folia Histochem Cytobiol 48: 46-57.
45. Walter R, Murasko D, Sierra F,. (1998) T-kininogen is a biomarker of senescence in rats. Mech Ageing Dev 106: 129-144.
46. Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, Rando TA,. (2005) Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433: 760-764.